Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction

Coronary Artery Disease

Volumn 20, Issue 1, 2009, Pages 9-14

  Nienhuis, Mark B ^a   Ottervanger, Jan Paul ^a,b   Dambrink, Jan Henk E ^a   De Boer, Menko Jan ^a   Hoorntje, Jan C A ^a   Gosselink, A T Marcel ^a   Suryapranata, Harry ^a   Van't Hof, Arnoud W J ^a  

^a ISALA HOSPITAL   (Netherlands)

^b Isala Klinieken ^*  (Netherlands)

Author keywords

Anterior; Ejection fraction; Infarct location; Myocardial infarction; Peak creatine kinase

Indexed keywords

CREATINE KINASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CREATINE KINASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NETHERLANDS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 58149269317     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32831bd875     Document Type: Article

References (30)

1. Shell WE, Kjekshus JK, Sobel BE. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine Phosphokinase activity. J Clin Invest 1971; 50:2614-2625.
2. Sobel BE, Bresnahan GF, Shell WE, Yoder RD. Estimation of infarct size in man and its relation to prognosis. Circulation 1972; 46:640-648.
3. Thanavaro S, Kleiger RE, Province MA, Hubert JW, Miller JP, Krone RJ, et al. Effect of infarct location on the in-hospital prognosis of patients with first transmural myocardial infarction. Circulation 1982; 66:742-747.
4. Hands ME, Lloyd BL, Robinson JS, de Klerk N, Thompson PL. Prognostic significance of electrocardiographic site of infarction after correction for enzymatic size of infarction. Circulation 1986; 73:885-891.
5. Stone PH, Raabe DS, Jaffe AS, Gustafson N, Muller JE, Turi ZG, et al. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol 1988; 11:453-463.
6. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41 021 patients. GUSTO-GUSTI investigators. Circulation 1995; 91:1659-1668.
7. Sciagra R, Imperiale A. Antoniucci D, Migliorini A, Parodi G, Comis G, et al. Relationship of infarct size and severity versus left ventricular ejection fraction and volumes obtained from 99mTc-sestamibi gated single-photon emission computed tomography in patients treated with primary percutaneous coronary intervention. Eur J Nucl Med Mol Imaging 2004; 31:969-974.
8. Elsman P, van t'Hof AWJ, de Boer MJ, Suryapranata H, Borm GF, Hoomtje JCA, et al. Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention Am Heart J 2006; 151:1239e9-1239e14.
9. Kandzan DE, Tcheng JE, Gersh BJ, Cox DA, Stuckey T, Turco M, et al. CADILLAC Investigators. Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction. Am Heart J 2006; 151:1286-1295.
10. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361:13-20.
11. Henriques JPS, Zijlstra F, van 't Hof AWJ, de Boer MJ, Dambrink JHE, Gosselink ATM, et al. Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location. Heart 2006; 92:75-79.
12. Halkin A, Stone GW, Grines CL, Cox DA, Rutherford BD, Esente P, et al. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol 2006; 47:951-961.
13. Mehta RH, O'Neill WW, Harjai KJ, Cox DA, Brodie BR, Boura J, et al.; PAMI and CADILLAC investigators. Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions. Am J Cardiol 2006; 97:817-822.
14. Henriques JPS, Zijlstra F, van t' Hof AWJ, de Boer MJ, Dambrink JHE, Gosselink ATM, et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 2003; 107:2115-2119.
15. Komowski R, Goldbourt U, Reicher-Reiss H, Reisin L, Haim M, Moshkovitz Y, et al. Prognostic significance of infarction location in patients with recurrent myocardial infarction. SPRINT study group. Cardiology 1997; 88:441-445.
16. Benhorin J, Moss AJ, Oakes D, Marcus F, Greenberg H, Dwyer EM Jr, et al. The prognostic significance of first myocardial infarction type (Q wave versus non-Q-wave) and Q wave location. J Am Coll Cardiol 1990; 15:1201-1207.
17. Behar S, Rabinowitz B, Zion M, Reicher-Reiss H, Kaplinsky E, Abinader E, et al. Immediate and long-term prognostic significance of a first anterior versus first inferior wall Q-wave acute myocardial infarction. Am J Cardiol 1993; 72:1366-1370.
18. McClements BM, Weyman AE, Newell JB, Picard MH. Echocardiographic determinants of left ventricular ejection fraction after acute myocardial infarction. Am Heart J 2000; 140:284-290.
19. Gomez JF, Zareba W, Moss AJ, McNitt S, Hall WJ. Prognostic value of location and type of myocardial infarction in the setting of advanced left ventricular dysfunction. Am J Cardiol 2007; 99:642-646.
20. Welty FK, Mittleman MA, Lewis SM, Healy RW, Shubrooks SJ, Muller JE. Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia Am J Cardiol 1995; 76:431-435.
21. Bulkley BH. Site and sequelae of myocardial infarction. N Engl J Med 1981; 305:337-338.
22. McKay RG, Pfeffer MA, Pasternak RC, Markis JE, Come PC, Nakao S, et al. Left ventricular remodeling after myocardial infarction - a corollary to infarct expansion. Circulation 1986; 74:693-702.
23. Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH. Left ventricular fibre architecture in man. Br Heart J 1981; 45:248-263.
24. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987; 75:299-306.
25. Bauters C, Lablanche JM, van Belle E, Niculescu R, Meurice T, McFadden EP, et al. Effects of coronary stenting on restenosis and occlusion after angioplasty of the culprit vessel in patients with recent myocardial infarction. Circulation 1997; 96:2854-2858.
26. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003; 349:1893-1906.
27. Doughty RN, Whalley GA, Walsh HA, Gamble GD, Lopez-Sendon J, Sharpe N. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation 2004; 109:201-206.
28. Savoye C, Equine O, Tricot O, Nugue O, Segrestin B, Sautiere K, et al. REmodelage VEntriculaire study group. Left ventricular remodeling after anterior wall acute myocardial infarction in modem clinical practice. Am J Cardiol 2006; 98:1144-1149.
29. O'Sullivan CA, Ramzy IS, Li W, Sutton R, Coats A, Gibson DG, et al. The effect of the localization of Q wave myocardial infarction on ventricular electromechanics. Int J Cardiol 2002; 84:241-247.
30. Sabia PJ, Powers ER, Ragosta M, Sarembock U, Burwell LR, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992; 327:1825-1831.